Search｜Photos & Images & Videos｜KYODO NEWS IMAGES INC

Sanofi To Sell Its Doliprane Production Subsidiary

Sanofi's Doliprane medecine boxes pictured in Camps-la-source, France on September 24, 2024. While Servier gave up on selling Biogaran at the beginning of September, the project to sell Opella, Sanofi’s healthcare subsidiary, which notably houses the iconic little yellow box, is still underway. Following the first indicative offers submitted in July, the takeover candidates had until 23 September to submit their firm takeover bids. Photo by Laurent Coust/ABACAPRESS.COM

E

Sanofi To Sell Its Doliprane Production Subsidiary

Sanofi's Doliprane medecine boxes pictured in Camps-la-source, France on September 24, 2024. While Servier gave up on selling Biogaran at the beginning of September, the project to sell Opella, Sanofi’s healthcare subsidiary, which notably houses the iconic little yellow box, is still underway. Following the first indicative offers submitted in July, the takeover candidates had until 23 September to submit their firm takeover bids. Photo by Laurent Coust/ABACAPRESS.COM

E

Sanofi To Sell Its Doliprane Production Subsidiary

Sanofi's Doliprane medecine boxes pictured in Camps-la-source, France on September 24, 2024. While Servier gave up on selling Biogaran at the beginning of September, the project to sell Opella, Sanofi’s healthcare subsidiary, which notably houses the iconic little yellow box, is still underway. Following the first indicative offers submitted in July, the takeover candidates had until 23 September to submit their firm takeover bids. Photo by Laurent Coust/ABACAPRESS.COM

E

Sanofi To Sell Its Doliprane Production Subsidiary

Sanofi's Doliprane medecine boxes pictured in Camps-la-source, France on September 24, 2024. While Servier gave up on selling Biogaran at the beginning of September, the project to sell Opella, Sanofi’s healthcare subsidiary, which notably houses the iconic little yellow box, is still underway. Following the first indicative offers submitted in July, the takeover candidates had until 23 September to submit their firm takeover bids. Photo by Laurent Coust/ABACAPRESS.COM

E

Sanofi To Sell Its Doliprane Production Subsidiary

Sanofi's Doliprane medecine boxes pictured in Camps-la-source, France on September 24, 2024. While Servier gave up on selling Biogaran at the beginning of September, the project to sell Opella, Sanofi’s healthcare subsidiary, which notably houses the iconic little yellow box, is still underway. Following the first indicative offers submitted in July, the takeover candidates had until 23 September to submit their firm takeover bids. Photo by Laurent Coust/ABACAPRESS.COM

E

Sanofi To Sell Its Doliprane Production Subsidiary

Sanofi's Doliprane medecine boxes pictured in Camps-la-source, France on September 24, 2024. While Servier gave up on selling Biogaran at the beginning of September, the project to sell Opella, Sanofi’s healthcare subsidiary, which notably houses the iconic little yellow box, is still underway. Following the first indicative offers submitted in July, the takeover candidates had until 23 September to submit their firm takeover bids. Photo by Laurent Coust/ABACAPRESS.COM

E

Sanofi To Sell Its Doliprane Production Subsidiary

Sanofi's Doliprane medecine boxes pictured in Camps-la-source, France on September 24, 2024. While Servier gave up on selling Biogaran at the beginning of September, the project to sell Opella, Sanofi’s healthcare subsidiary, which notably houses the iconic little yellow box, is still underway. Following the first indicative offers submitted in July, the takeover candidates had until 23 September to submit their firm takeover bids. Photo by Laurent Coust/ABACAPRESS.COM

E

Sanofi To Sell Its Doliprane Production Subsidiary

Sanofi's Doliprane medecine boxes pictured in Camps-la-source, France on September 24, 2024. While Servier gave up on selling Biogaran at the beginning of September, the project to sell Opella, Sanofi’s healthcare subsidiary, which notably houses the iconic little yellow box, is still underway. Following the first indicative offers submitted in July, the takeover candidates had until 23 September to submit their firm takeover bids. Photo by Laurent Coust/ABACAPRESS.COM

E

Sanofi To Sell Its Doliprane Production Subsidiary

Sanofi's Doliprane medecine boxes pictured in Camps-la-source, France on September 24, 2024. While Servier gave up on selling Biogaran at the beginning of September, the project to sell Opella, Sanofi’s healthcare subsidiary, which notably houses the iconic little yellow box, is still underway. Following the first indicative offers submitted in July, the takeover candidates had until 23 September to submit their firm takeover bids. Photo by Laurent Coust/ABACAPRESS.COM

E

Sanofi To Sell Its Doliprane Production Subsidiary

Sanofi's Doliprane medecine boxes pictured in Camps-la-source, France on September 24, 2024. While Servier gave up on selling Biogaran at the beginning of September, the project to sell Opella, Sanofi’s healthcare subsidiary, which notably houses the iconic little yellow box, is still underway. Following the first indicative offers submitted in July, the takeover candidates had until 23 September to submit their firm takeover bids. Photo by Laurent Coust/ABACAPRESS.COM

E

Sanofi To Sell Its Doliprane Production Subsidiary

Sanofi's Doliprane medecine boxes pictured in Camps-la-source, France on September 24, 2024. While Servier gave up on selling Biogaran at the beginning of September, the project to sell Opella, Sanofi’s healthcare subsidiary, which notably houses the iconic little yellow box, is still underway. Following the first indicative offers submitted in July, the takeover candidates had until 23 September to submit their firm takeover bids. Photo by Laurent Coust/ABACAPRESS.COM

E

Sanofi To Sell Its Doliprane Production Subsidiary

Sanofi's Doliprane medecine boxes pictured in Camps-la-source, France on September 24, 2024. While Servier gave up on selling Biogaran at the beginning of September, the project to sell Opella, Sanofi’s healthcare subsidiary, which notably houses the iconic little yellow box, is still underway. Following the first indicative offers submitted in July, the takeover candidates had until 23 September to submit their firm takeover bids. Photo by Laurent Coust/ABACAPRESS.COM

E

Sanofi To Sell Its Doliprane Production Subsidiary

Sanofi's Doliprane medecine boxes pictured in Camps-la-source, France on September 24, 2024. While Servier gave up on selling Biogaran at the beginning of September, the project to sell Opella, Sanofi’s healthcare subsidiary, which notably houses the iconic little yellow box, is still underway. Following the first indicative offers submitted in July, the takeover candidates had until 23 September to submit their firm takeover bids. Photo by Laurent Coust/ABACAPRESS.COM

E

Sanofi To Sell Its Doliprane Production Subsidiary

Sanofi's Doliprane medecine boxes pictured in Camps-la-source, France on September 24, 2024. While Servier gave up on selling Biogaran at the beginning of September, the project to sell Opella, Sanofi’s healthcare subsidiary, which notably houses the iconic little yellow box, is still underway. Following the first indicative offers submitted in July, the takeover candidates had until 23 September to submit their firm takeover bids. Photo by Laurent Coust/ABACAPRESS.COM

E

BOTSWANA-EU-COOPERATION

(221123) -- GABORONE, Nov. 23, 2022 (Xinhua) -- Botswana's Finance Minister Peggy Serame (R) shakes hands with Petra Pereyra, European Union ambassador to Botswana and the Southern African Development Community, during the launch of the Multi-Annual Indicative Program (MIP) in Gaborone, Botswana, Nov. 22, 2022. Botswana and the EU on Tuesday launched the MIP, covering the period of 2021-27 with an initial grant of 16 million euros. (Photo by Tshekiso Tebalo/Xinhua)

E

BOTSWANA-EU-COOPERATION

(221123) -- GABORONE, Nov. 23, 2022 (Xinhua) -- Petra Pereyra, European Union ambassador to Botswana and the Southern African Development Community, speaks during the launch of the Multi-Annual Indicative Program (MIP) in Gaborone, Botswana, Nov. 22, 2022. Botswana and the EU on Tuesday launched the MIP, covering the period of 2021-27 with an initial grant of 16 million euros. (Photo by Tshekiso Tebalo/Xinhua)

E

A glimpse of endangered ducks predations in NE China

STORY: A glimpse of endangered waterfowl catching fish in NE China DATELINE: Oct. 14, 2022 LENGTH: 00:00:41 LOCATION: CHANGCHUN, China CATEGORY: ENVIRONMENT SHOTLIST: 1. various of endangered ducks catching fish STORYLINE: Rare video footage of Chinese mergansers catching fish was captured in northeast China's Jilin Province. It is an endangered bird species under first-class national protection. This beautiful and rare waterfowl has been living on the planet for over ten million years. It is called a "living fossil" and it's an indicative species of the wetlands' ecological health. It is listed as endangered on the International Union for Conservation of Nature's red list, with Russia's Far East and northeast China officially regarded as the bird's major reproduction bases. Xinhua News Agency correspondents reporting from Changchun, China. (XHTV)

E

Torii,Suwa Shrine

This hand-tinted photograph taken around 1887 depicts the view of Suwa Shinto Shrine from the Ninotorii (second torii gate) inside the Great Torii Gate. The Donko Teahouse is visible on the right. The Western-style building on the approach is indicative of the tide of modernization in the mid-Meiji Period.==Date:unknown, Place:Nagasaki, Photo:A. Farsari, (Credit:Nagasaki University Library/Kyodo News Images) [Cabinet Number81‐34‐0]

E

Precincts of Suwa Shrine

This photograph taken around 1887 shows the Middle Gate at Suwa Shinto Shrine. This is the main shrine in Nagasaki and it is famous for its autumn Kunchi Festival. This is a staged photograph with people posing on the stairs in front of the Middle Gate. The Western-style lamp on the left is indicative of the tide of modernization in Nagasaki.==Date:unknown, Place:Nagasaki, Photo:unknown, (Credit:Nagasaki University Library/Kyodo News Images) [Cabinet Number73‐30‐0]

E

Women making tea

Three dressed-up children are reading picture books while tea is being served. Their hair is arranged in the momoware style. The fusuma sliding doors are illustrated with cherry blossoms, indicative of the season of the year.==Date:unknown, Place:unknown, Photo:Tamamura Kozaburo, (Credit:Nagasaki University Library/Kyodo News Images) [Cabinet Number48‐5‐0]